Browsing by Title
Now showing items 3485-3493 of 3493
-
X-linked Ohdo syndrome due to a novel MED12 variant detected by Rapid Exome Sequencing
(Wolters Kluwer, 2022-04-01) -
Xenogeneic human umbilical cord-derived mesenchymal stem cells reduce mortality in rats with acute respiratory distress syndrome complicated by sepsis.
(Oncotarget, 2017-07-11)This study tested the hypothesis that xenogeneic human umbilical cord-derived mesenchymal stem cell (HUCDMSC) therapy would improve survival rates in rats with acute respiratory distress-syndrome (ARDS, induction by 48 h ... -
YIPF5 mutations cause neonatal diabetes and microcephaly through endoplasmic reticulum stress
(American Society for Clinical Investigation, 2020-12-01)Neonatal diabetes is caused by single gene mutations reducing pancreatic β cell number or impairing β cell function. Understanding the genetic basis of rare diabetes subtypes highlights fundamental biological processes in ... -
You can't beat experience, but you can cheat it.
(Elsevier, 2013-02) -
Young adults' perspectives on living with kidney failure: a systematic review and thematic synthesis of qualitative studies.
(BMJ, 2018-01)Young adults fare worse than younger adolescents or older adults on a broad range of health indicators. Those with a chronic illness such as renal failure are a particularly vulnerable group, who experience poor outcomes ... -
Z59.5 - The most important colorectal diagnosis of all?
(Wiley, 2022-10-01)Colorectal surgeons and public health doctors do not seem like an obvious match, but we live in unique times and consequently, now more than ever, there is a necessity for the colorectal community to remember the breadth ... -
Zanubrutinib for the treatment of MYD88 wild-type Waldenström macroglobulinemia: a substudy of the phase 3 ASPEN trial.
(American Society of Hematology, 2020-12-08)Patients with Waldenström macroglobulinemia (WM) lacking activating mutations in the MYD88 gene (MYD88WT) have demonstrated relatively poor outcomes to ibrutinib monotherapy, with no major responses reported in a phase 2 ... -
Zinc transporter 8 autoantibody testing requires age-related cut-offs
(BMJ, 2021-08-01)INTRODUCTION: Zinc transporter 8 autoantibodies (ZnT8A) are biomarkers of beta cell autoimmunity in type 1 diabetes that have become more widely available to clinicians in recent years. Robust control population-defined ...